Overview

A Study of Two Formulations (Both Refrigerated and Room Temperature) Using an Autoinjector Device in Healthy Participants

Status:
Recruiting
Trial end date:
2021-12-22
Target enrollment:
Participant gender:
Summary
The main purpose of the study is to assess the injection site pain intensity of two formulations using prefilled autoinjector device in healthy participants.
Phase:
Phase 1
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Mannitol